The antiproliferative effect of mulberry (Morus alba L.) plant on hepatocarcinoma cell line HepG2

Egyptian Journal of Medical Human Genetics

Volumn 14, Issue 4, 2013, Pages 375-382

  Fathy, Shadia A ^a   Singab, Abdel Nasser B ^b   Agwa, Sara A ^c   Abd El Hamid, Dalia M ^c   Zahra, Fatma A ^d   Abd El Moneim, Sawsan M ^d  

^a Ain Shams University   (Egypt)

^b African Union Organization St Abbassia   (Egypt)

^c AIN SHAMS UNIVERSITY   (Egypt)

^d Saint Fatima Square Heliopolis   (Egypt)

Author keywords

Alfa fetoprotein; Antiproliferative effect; HepG2 cell line; Morus alba L.; NF B

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; DIMETHYL SULFOXIDE; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METHANOL; MULBERRY EXTRACT; WATER;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL COUNT; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MORUS ALBA; PLANT LEAF;

EID: 84885365310     PISSN: 11108630     EISSN: 20902441     Source Type: Journal    
DOI: 10.1016/j.ejmhg.2013.07.001     Document Type: Article

References (29)

1. Anwar W., Khaled Hussein M., Amra Hassan A., El-Nezami Hani, Loffred Christopher A. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention. Mutat Res 2008, 659:176-184.
2. Ahmad Areeba, Ahmad Riaz Understanding the mechanism of hepatic fibrosis and potential therapeutic approaches. Saudi J Gastroenterol 2012, 18(3):155-167.
3. WHO Global Surveillance, Control of Hepatitis C Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 2010, 6:35-47.
4. Chon Sang-Uk, Kim Young-Min, Park Yun-Jum, Heo Buk-Gu, Park Yong-Seo, Gorinstein Shela Antioxidant and antiproliferative effects of methanol extracts from raw and fermented parts of mulberry plant (Morus alba L.). Eur Food Res Technol 2009, 230:231-237.
5. Srivastava S., Kapoor R., Thathola A., Srivastava R.P. Int J Food Sci Nutr 2003, 54:411-416.
6. Harauma A., Murayama T., Ikeyama K., Sano H., Arai H., Takano R., et al. Mulberry leaf powder prevents atherosclerosis in apolipoprotein E-deficient mice. Biochem Biophys Res Commun 2007, 358:751-756.
7. Doi K., Kojima T., Makino M., Kimura Y., Fujimoto Y. Studies on the constituents of the leaves of Morus alba L. Chem Pharm Bull 2001, 49:151-153.
8. Naowaratwattana Wanalaya, De-Eknamkul Wanchai, De Mejia Elvira Gonzalez Phenolic-containing organic extracts of mulberry (Morus Alba L.) Leaves inhibit HepG2 hepatoma cells through G2/M phase arrest and inhibition of topoisomerase IIx activity. J Med Food 2010, 13(5):1045-1056.
9. Priya Sulochana Medicinal values of mulberry. J Pharm Res 2012, 5(7):3588-3596.
10. Katsube T., Imawaka N., Kawano Y., Yamazaki Y., Shiwaku K., Yamane Y. Antioxidant flavonol glycosides in mulberry (Morus alba L.) leaves isolated based on LDL antioxidant activity. Food Chem 2006, 97:25-31.
11. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real time quantitative PCR, the 2δδCT. Methods 2001, 25:402-408.
12. Uotila M., Ruoslahti E., Engvall E. Two-site sandwich enzyme immunoassay with monoclonal antibodies to human alpha-fetoprotein. J Immunol Methods 1981, 42:11-15.
13. Wolf R.L. Methods and techniques in clinical chemistry 1972, Willey Interscience, NY.
14. Tietz N.W. Fundamentals of clinical chemistry 1987, W.B. Saunders Co., Philadelphia (PA), p. 940.
15. Young D.S. Effects of drugs on clinical laboratory tests 1995, AACC Press, Washington, D.C. 4th ed.
16. Dillard C.J., German J.B. Phytochemicals, nutraceuticals and human health. J Sci Food Agric 2010, 80:1744-1756.
17. Takuya K., Yukikazu Y. Apoptosis-inducing activity of ethanol extracts from the tea of mulberry (Morus alba) leaves in HL-60 cells. J Jpn Soc Food Sci Technol 2009, 49:195-198.
18. Guo, Song Li, Wang Zejian, Zhao Wenjuan, Mao Wenwei, Yin Ming Panaxydol inhibits the proliferation and induces the differentiation of human hepatocarcinoma cell line HepG2. Chem Biol Interact 2009, 181:138-143.
19. Okamoto T., Sanda T., Asamitsu K. NF-kappa B signaling and carcinogenesis. Curr Pharm Des 2007, 13:447-462.
20. Nabel G.J., Verma I.M. Proposed NF-kappa B/I kappa B family nomenclature. Genes Dev 1993, 7:57-63.
21. Aggarwal B.B. Nuclear factor-kappaB: the enemy within. Cancer Cell 2004, 6(3):203-208.
22. Takada Y., Kobayashi Y., Aggarwal B.B. Evodiamine abolishes constitutive and inducible NF-kappaB activation by inhibiting IkappaBalpha kinase activation, thereby suppressing NF-kappaB-regulated antiapoptotic and metastatic gene expression, up-regulating apoptosis, and inhibiting invasion. J Biol Chem 2003, 280(17):17203-17212.
23. Aggarwal Bharat B., Shishodia Shishir Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 2006, 1:1397-1421.
24. Lee Jenq-Chang, Wonb Shen-Jeu, Chao Chien-Lin, Wub Feng-Ling, Liu Hsiao-Shen, Ling Pin, et al. Morusin induces apoptosis and suppresses NF-kB activity in human colorectal cancer HT-29 cells. Biochem Biophys Res Commun 2011, 372:236-242.
25. Arsura Marcello, Cavin Lakita G. Nuclear factor-κB and liver carcinogenesis. Cancer Lett 2007, 229:157-169.
26. Bredaki F.E., Poon L.C., Birdir C., Escalante D., Nicolaides K.H. First-trimester screening for neural tube defects using alpha-fetoprotein. Fetal Diagn Ther 2012, 31(2):109-114.
27. Kinasiewicz1 Andrzej, Kawiak Jerzy, Weryński1 Andrzej 3D matrigel culture improves differentiated functions of HepG2 cells in vitro. Biocybernet Biomed Eng 2006, 6(4):47-55.
28. Notas G., Nifli A.-P., Kampa M., Vercauteren J., Kouroumalis E., Castanas E. Resveratrol exerts its antiproliferative effect on HepG2 hepatocellular carcinoma cells, by inducing cell cycle arrest, and NOS activation. Biochim Biophys Acta 2006, 1760(11):1657-1666.
29. Hanachi, Asmah Kua, Motalleb, Fauziah Cytotoxic effect of barberries vulgaris fruit extract on the proliferation of human liver cancer cell line and its antioxidant properties. Int J Cancer Res 2006, 2(1):1-9.